Relative Strength Alert For Xenon Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of Xenon Pharmaceuticals Inc ( XENE) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $11.96 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 61.4. A bullish investor could look at XENE's 29.5 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of XENE shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Xenon Pharmaceuticals Inc 1 Year Performance Chart

Looking at the chart above, XENE's low point in its 52 week range is $9.21 per share, with $23.50 as the 52 week high point — that compares with a last trade of $12.30.

More from Stocks

Dow Fluctuates, Nasdaq Strikes Record High

Dow Fluctuates, Nasdaq Strikes Record High

GE's Exit From Dow Could Be a Blessing in Disguise, Goldman Says

GE's Exit From Dow Could Be a Blessing in Disguise, Goldman Says

Own Retail Stocks? This Chart Will Make You Want to Instantly Cash Out

Own Retail Stocks? This Chart Will Make You Want to Instantly Cash Out

Disney CEO Bob Iger Touts Benefits of His Firm's Deal for Fox Beyond Just Money

Disney CEO Bob Iger Touts Benefits of His Firm's Deal for Fox Beyond Just Money

2 Things Fed Chairman Jerome Powell Just Said Upset Investors

2 Things Fed Chairman Jerome Powell Just Said Upset Investors